Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion

Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion

BackgroundMultiple myeloma (MM) is the second most common hematological malignancy that still lacks effective clinical treatments. In particular, MM with central nervous system (CNS) invasion occurs rarely. Although B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor-T (CAR-T) cell t...

Full description

Bibliographic Details
Main Authors: Ting Wang, Ting He, Lie Ma, Yazi Yang, Ru Feng, Yanping Ding, Yueming Shan, Bing Bu, Feifei Qi, Fei Wu, Xin-an Lu, Hui Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
CAR-T
BCMA
multiple myeloma
central nervous system
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.854448/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.854448/full

Similar Items